CYTK – Kudos to the analyst from Pacific Growth Equities (Greg Wade), who confronted management on today’s CC about the spin. >> Wade: “If GSK had not decided not to go forward with the studies you’re proposing, would not the drug have reverted back to you for free anyway?” CYTK CEO: “I’m not sure it makes sense to get into what could have been instead of what did happen.” << LOL